Design Therapeutics Inc (NASDAQ:DSGN) price on Wednesday, May 09, remained unchanged to $4.69.
A look at the stock’s price movement, the close in the last trading session was $4.69. Turning to its 52-week performance, $8.47 and $1.94 were the 52-week high and 52-week low respectively. Overall, DSGN moved 25.74% over the past month.
Design Therapeutics Inc’s market cap currently stands at around $264.94 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DSGN is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
DSGN’s current price about 24.35% and 37.04% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 72.20, while 7-day volatility ratio is 11.07% and 7.97% in the 30-day chart. Further, Design Therapeutics Inc (DSGN) has a beta value of 1.91, and an average true range (ATR) of 0.33.
If we refocus on Design Therapeutics Inc (NASDAQ:DSGN), historical trading data shows that trading volumes averaged 290.02K over the past 3 months. The company’s latest data on shares outstanding shows there are 56.47 million shares.
The 41.56% of Design Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 44.46% of the company’s shares. Current price change has pushed the stock 76.98% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DSGN stock continues to rise going into the next quarter.
